Interferon Regulatory Factor 9 Protects Against Cardiac Hypertrophy by Targeting Myocardin

Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway

(2013) Ke Chen et al.   BASIC RESEARCH IN CARDIOLOGY

Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy

(2013) Jing Lu et al.   BASIC RESEARCH IN CARDIOLOGY

Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice

(2013) Xin-An Wang et al.   HEPATOLOGY

Role of Interferon Regulatory Factor 4 in the Regulation of Pathological Cardiac Hypertrophy

(2013) Ding-Sheng Jiang et al.   HYPERTENSION

HCV NS5A and IRF9 compete for CypA binding

(2012) Michael Bobardt et al.   JOURNAL OF HEPATOLOGY

Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction

(2011) Jinfeng Xiao et al.   BASIC RESEARCH IN CARDIOLOGY

Transcriptional Control of Adipose Lipid Handling by IRF4

(2011) Jun Eguchi et al.   Cell Metabolism

The synergistic effects of cytomegalovirus IE2 and myocardin on cardiomyocyte hypertrophy

(2011) Jun Zhou et al.   FEBS LETTERS

Regulation of immunity and oncogenesis by the IRF transcription factor family

(2010) David Savitsky et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The IP 3 Receptor Regulates Cardiac Hypertrophy in Response to Select Stimuli

(2010) Hiroyuki Nakayama et al.   CIRCULATION RESEARCH

Cellular FLICE-Inhibitory Protein Protects Against Cardiac Remodeling Induced by Angiotensin II in Mice

(2010) Hongliang Li et al.   HYPERTENSION

Tumor Suppressor A20 Protects Against Cardiac Hypertrophy and Fibrosis by Blocking Transforming Growth Factor-β–Activated Kinase 1–Dependent Signaling

(2010) He Huang et al.   HYPERTENSION

Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies

(2010) Bianca C. Bernardo et al.   PHARMACOLOGY & THERAPEUTICS

Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload

(2010) H. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice

(2009) Thomas E. Callis et al.   JOURNAL OF CLINICAL INVESTIGATION

IRF9 is a Key Factor for Eliciting the Antiproliferative Activity of IFN-α

(2009) Takaya Tsuno et al.   JOURNAL OF IMMUNOTHERAPY

Left Ventricular Hypertrophy and Clinical Outcomes in Hypertensive Patients

(2008) L. M. Ruilope et al.   AMERICAN JOURNAL OF HYPERTENSION

The IRF Family Transcription Factors in Immunity and Oncogenesis

(2008) Tomohiko Tamura et al.   Annual Review of Immunology

Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis

(2008) Zhouyan Bian et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE